Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice.

Zeng X, Lin Y, Yin C, Zhang X, Ning BF, Zhang Q, Zhang JP, Qiu L, Qin XR, Chen YX, Xie WF.

Hepatology. 2011 Dec;54(6):2036-47. doi: 10.1002/hep.24647.

PMID:
21898499
[PubMed - indexed for MEDLINE]
2.

C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.

Shi YC, Zhao H, Yin C, Zeng X, Zhang Q, Xu WP, Wei J, Chen F, Xie WF.

Dig Liver Dis. 2013 Oct;45(10):844-51. doi: 10.1016/j.dld.2013.03.013. Epub 2013 Jun 28.

PMID:
23816696
[PubMed - indexed for MEDLINE]
3.

Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma.

Yu HT, Yu M, Li CY, Zhan YQ, Xu WX, Li YH, Li W, Wang ZD, Ge CH, Yang XM.

J Biol Chem. 2009 May 15;284(20):13335-47. doi: 10.1074/jbc.M806393200. Epub 2009 Mar 19.

PMID:
19304666
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors.

Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Fleishman DI, Engelhardt NV, Duncan SA.

Hepatology. 2004 Apr;39(4):1038-47.

PMID:
15057908
[PubMed - indexed for MEDLINE]
5.

Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.

Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, Hou JL, Deng X, Zhang JP, Han ZG, Xie WF.

Hepatology. 2008 Nov;48(5):1528-39. doi: 10.1002/hep.22510.

PMID:
18925631
[PubMed - indexed for MEDLINE]
6.

Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.

Yue X, Zhang Z, Liang X, Gao L, Zhang X, Zhao D, Liu X, Ma H, Guo M, Spear BT, Gong Y, Ma C.

Gastroenterology. 2012 Jun;142(7):1559-70.e2. doi: 10.1053/j.gastro.2012.02.049. Epub 2012 Mar 6.

PMID:
22406477
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, Wang Z, Ding G, Zhuang SM, Zheng L, Tao W, Cao X.

J Biol Chem. 2011 Oct 21;286(42):36677-85. doi: 10.1074/jbc.M111.270561. Epub 2011 Aug 30.

PMID:
21878637
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.

Yamashita T, Honda M, Nio K, Nakamoto Y, Yamashita T, Takamura H, Tani T, Zen Y, Kaneko S.

Cancer Res. 2010 Jun 1;70(11):4687-97. doi: 10.1158/0008-5472.CAN-09-4210. Epub 2010 May 18.

PMID:
20484035
[PubMed - indexed for MEDLINE]
Free Article
9.

Nuclear α1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells.

Santamaria M, Pardo-Saganta A, Alvarez-Asiain L, Di Scala M, Qian C, Prieto J, Avila MA.

Gastroenterology. 2013 Apr;144(4):818-828.e4. doi: 10.1053/j.gastro.2012.12.029. Epub 2013 Jan 4.

PMID:
23295442
[PubMed - indexed for MEDLINE]
10.

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500. Epub 2011 Nov 7.

PMID:
22056881
[PubMed - indexed for MEDLINE]
11.

Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.

Wei S, Xiong M, Zhan DQ, Liang BY, Wang YY, Gutmann DH, Huang ZY, Chen XP.

Carcinogenesis. 2012 Mar;33(3):538-47. doi: 10.1093/carcin/bgr319. Epub 2012 Jan 5.

PMID:
22226916
[PubMed - indexed for MEDLINE]
Free Article
12.

Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.

Wang F, He L, Dai WQ, Xu YP, Wu D, Lin CL, Wu SM, Cheng P, Zhang Y, Shen M, Wang CF, Lu J, Zhou YQ, Xu XF, Xu L, Guo CY.

PLoS One. 2012;7(12):e50638. doi: 10.1371/journal.pone.0050638. Epub 2012 Dec 20.

PMID:
23284640
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines.

Pelletier L, Rebouissou S, Vignjevic D, Bioulac-Sage P, Zucman-Rossi J.

BMC Cancer. 2011 Oct 5;11:427. doi: 10.1186/1471-2407-11-427.

PMID:
21975049
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.

Yang W, Wang C, Lin Y, Liu Q, Yu LX, Tang L, Yan HX, Fu J, Chen Y, Zhang HL, Tang L, Zheng LY, He YQ, Li YQ, Wu FQ, Zou SS, Li Z, Wu MC, Feng GS, Wang HY.

J Hepatol. 2012 Sep;57(3):613-20. doi: 10.1016/j.jhep.2012.04.024. Epub 2012 May 19.

PMID:
22612999
[PubMed - indexed for MEDLINE]
15.

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.

Yang H, Fang F, Chang R, Yang L.

Hepatology. 2013 Jul;58(1):205-17. doi: 10.1002/hep.26315. Epub 2013 May 14.

PMID:
23401231
[PubMed - indexed for MEDLINE]
16.

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.

Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y.

BMC Cancer. 2012 May 4;12:166. doi: 10.1186/1471-2407-12-166.

PMID:
22559167
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.

Zhao J, Zhang X, Shi M, Xu H, Jin J, Ni H, Yang S, Dai J, Wu M, Guo Y.

Hepatology. 2006 Jul;44(1):205-15.

PMID:
16799960
[PubMed - indexed for MEDLINE]
18.

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.

Hepatology. 2008 Jun;47(6):1955-63. doi: 10.1002/hep.22256.

PMID:
18433021
[PubMed - indexed for MEDLINE]
19.

Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.

Yin C, Wang PQ, Xu WP, Yang Y, Zhang Q, Ning BF, Zhang PP, Zhou WP, Xie WF, Chen WS, Zhang X.

Hepatology. 2013 Dec;58(6):1964-76. doi: 10.1002/hep.26573. Epub 2013 Oct 22.

PMID:
23775631
[PubMed - indexed for MEDLINE]
20.

Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.

Qi R, An H, Yu Y, Zhang M, Liu S, Xu H, Guo Z, Cheng T, Cao X.

Cancer Res. 2003 Dec 1;63(23):8323-9.

PMID:
14678992
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk